Say Hello!
Don’t be shy.

   

Acquisition Tag

Dr. Gary Allenby and Kathy Dodgson, founders and directors of Aurelia Bioscience, are pleased to announce that after 10 years of success as a standalone biology contract research organisation, the company has been acquired by its collaborator- Charnwood Molecular. To facilitate this agreement, Aurelia Bioscience,...

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO servicing the global pharmaceutical and biotechnology market, is pleased to announce the acquisition of the assay development and biological screening provider, Aurelia Bioscience. The sector-leading expertise and technology development within Aurelia Bioscience will enable and enhance Charnwood’s provision...

RenaSci was founded in 2001 by Dr Sharon Cheetham, Dr Rob Jones and Professor David Heal, providing an integrated blend of in vivo pharmacology consultancy and experimental services, helping clients from all sectors of the pharmaceutical and biotech industry to maximise their research productivity and streamline drug...

Excellerate Bioscience is delighted that a close relationship with Omass Therapeutics, built over 18 months, has helped contribute to their success in securing extended series A funding. During this period, Excellerate assembled a dedicated team of expert pharmacologists focussed exclusively on driving forward the Omass...

Via http://www.entrustpeople.co.uk Entrust People are delighted to announce Horton International UK have joined their parent company, Entrust Resource Solutions. This first step is part of ambitious growth plans from Entrust Resource Solutions which will see the group provide comprehensive recruitment solutions across the life sciences sector, working...